-
公开(公告)号:WO2021040519A1
公开(公告)日:2021-03-04
申请号:PCT/NL2020/050527
申请日:2020-08-26
Applicant: STICHTING VUMC , STICHTING VU
Inventor: RUIJTER, Eelco , RONG, Mark Karsten , SPEER, Alexander , BITTER, Wilhelmus , COLE, Stewart Thomas
IPC: C07D285/08 , C07D417/04 , A61K31/4436 , A61K31/42 , A61K31/426 , A61K31/4245 , A61K31/433 , A61K31/506 , A61P31/04 , A61P31/06
Abstract: The invention relates to compounds and pharmaceutically acceptable salts thereof, and to their medical use. Exemplary medical uses are the prevention and treatment of a bacterial infection, for example, a mycobacterial infection, such as a Mycobacterium tuberculosis infection, e.g., in a respiratory system and/or extrapulmonic. The invention further relates to a use of such compounds, pharmaceutically acceptable salts thereof or prodrugs of the compounds as chemotherapeutic agents. Also, the invention relates to a use of such compounds, pharmaceutically acceptable salts thereof or prodrugs of the compounds for inhibiting mycobacterial type VII secretion. The compounds have the following formula (Ia), wherein Q and X are, respectively, CH and C, CR2 and C, CH and N, CR2 and N, or N and C; R1 is hydrogen, halide or optionally substituted linear or branched alkoxy having 1 or 2 carbon atoms; R2 is independently selected from hydrogen, halide or optionally substituted linear or branched alkoxy having 1 or 2 carbon atoms, and R3 is optionally substituted linear or branched alkoxy having 1-6 carbon atoms, haloalkyl having 1-6 carbon atoms, n-propyl, 2-propenyl, 2-propynyl, or n-pentyl, or a pharmaceutically acceptable salt of the compound, for use in the prevention or treatment of a bacterial infection.
-
公开(公告)号:EP4021898A1
公开(公告)日:2022-07-06
申请号:EP20761920.6
申请日:2020-08-26
Applicant: Stichting VUmc , Stichting VU
Inventor: RUIJTER, Eelco , RONG, Mark Karsten , SPEER, Alexander , BITTER, Wilhelmus , COLE, Stewart Thomas
IPC: C07D285/08 , C07D417/04 , A61K31/4436 , A61K31/42 , A61K31/426 , A61K31/4245 , A61K31/433 , A61K31/506 , A61P31/04 , A61P31/06
-